Lord Abbett Health Care Fund Class R5 (LHCTX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
18.50
-0.23 (-1.23%)
Jul 11, 2025, 4:00 PM EDT
Fund Assets7.16M
Expense Ratio0.78%
Min. Investment$1,500
Turnover88.00%
Dividend (ttm)0.11
Dividend Yield0.60%
Dividend Growthn/a
Payout Frequencyn/a
Ex-Dividend DateNov 26, 2024
Previous Close18.73
YTD Return-4.34%
1-Year Return-9.32%
5-Year Return28.27%
52-Week Low16.71
52-Week High21.07
Beta (5Y)n/a
Holdings58
Inception DateJul 31, 2019

About LHCTX

Lord Abbett Health Care Fund Class R5 is an actively managed mutual fund that focuses on delivering long-term capital growth by investing primarily in equity securities of companies within the health care sector. The fund’s portfolio is diversified across areas such as pharmaceuticals, biotechnology, medical devices, and health care services. Managed by Lord Abbett’s experienced investment team, the fund seeks to capitalize on innovation, demographic changes, and advancements within global health care industries. A distinguishing feature of this fund is its commitment to specialization: approximately 96% of its assets are allocated to health care holdings, with a small balance in repurchase agreements. The fund typically holds around 61 securities, providing both sector concentration and diversified exposure within health care. Designed for institutional investors, the Class R5 share class is structured with a lower net expense ratio relative to other share classes, potentially enhancing cost efficiency for larger organizations. With significant assets under management and a portfolio turnover rate that reflects an active approach, the Lord Abbett Health Care Fund Class R5 plays a critical role for investors seeking targeted participation in health care industry growth, making it a relevant vehicle in sector-based investment strategies.

Fund Family Lord Abbett
Category Health
Stock Exchange NASDAQ
Ticker Symbol LHCTX
Share Class Class R5
Index MSCI ACWI/Health Care NR Index

Performance

LHCTX had a total return of -9.32% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.15%.

Chart

Bar chart with 6 bars.
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying values. Data ranges from -9.318170677907943 to 7.145.
End of interactive chart.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

SymbolShare ClassExpense Ratio
LHCOXClass F30.68%
LHCVXClass R60.68%
LHCFXClass F0.78%
LHCIXClass I0.78%

Top 10 Holdings

44.38% of assets
NameSymbolWeight
Eli Lilly and CompanyLLY11.69%
Boston Scientific CorporationBSX4.91%
Intuitive Surgical, Inc.ISRG4.88%
Stryker CorporationSYK3.68%
Gilead Sciences, Inc.GILD3.67%
argenx SEARGX3.43%
Natera, Inc.NTRA3.20%
Tarsus Pharmaceuticals, Inc.TARS3.19%
Abbott LaboratoriesABT2.86%
AstraZeneca PLCAZN2.84%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Nov 26, 2024$0.1101Nov 26, 2024
Nov 22, 2022$0.0233Nov 22, 2022
Nov 23, 2021$1.4724Nov 23, 2021
Nov 24, 2020$2.3182Nov 24, 2020
Nov 21, 2019$0.0069Nov 21, 2019
Full Dividend History